Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)
NCT03508258 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2022-06-30
Summary
Study of patients with nonvalvular atrial fibrillation (NVAF) who are newly prescribed NOACs (Novel Oral Anticoagulants) in routine clinical practice in England
Conditions
- Non-valvular Atrial Fibrillation
Interventions
- OTHER
-
Non-interventional
Non-interventional
- OTHER
-
Non-Interventional
Non-Interventional
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-09-01
- Primary Completion
- 2018-09-01
- Completion
- 2018-09-01
Countries
- United States
Study Locations
More Related Trials
-
Atrial Fibrillation Incidence, Risk Factors and Genetics
NCT00021905 ·Status: COMPLETED
-
A Study to Collect Information on the Characteristics of Elderly Belgian Patients With NVAF That Are Treated With a NOAC for This Indication With a Special Focus on Their Fear of Bleeding While Using a NOAC vs the Clinical Benefit of a NOAC of Thrombosis/Stroke Prevention.
NCT04722679 ·Status: COMPLETED
-
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
NCT02608099 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan
NCT05027061 ·Status: COMPLETED
-
Evaluating Quality of Life of AF Patients Following a Bleed
NCT04921176 ·Status: COMPLETED
-
Evaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the US
NCT02674594 ·Status: COMPLETED
-
Treatment and Outcomes of Atrial Fibrillation and Acute Coronary Syndrome in Sweden
NCT03311139 ·Status: COMPLETED
-
Management of Antithrombotic TherApy in Patients With Atrial Fibrillation or DevelOping AtRial Fibrillation During Hospitalization for PCI
NCT03656523 ·Status: COMPLETED
-
A Study to Assess the Effectiveness of an Atrial Fibrillation (AF) Risk Prediction Algorithm and Diagnostic Test in Identifying Patients With AF.
NCT04045639 ·Status: COMPLETED
-
A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation
NCT00938730 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding
NCT05471505 ·Status: COMPLETED
-
Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring
NCT01706146 ·Status: COMPLETED ·Phase: PHASE4
-
Prediction of Bleeding Risk After Anticoagulant Therapy for Atrial Fibrillation Based on Proteomics and Metabolomics
NCT05181774 ·Status: UNKNOWN
-
Study in Atrial Fibrillation (AF) Patients at High Risk of Stroke
NCT05421533 ·Status: TERMINATED
-
Non-interventional Study on Patients With Atrial Fibrillation and Cancer
NCT03909386 ·Status: COMPLETED
-
COhort of antithrOmbotic Use and cLinical Outcomes in Patients With Atrial Fibrillation (COOL-AF) Phase 2
NCT06396299 ·Status: RECRUITING
-
Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury and Effect of Statins
NCT00321802 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Thrombotic Status in Patients With Atrial Fibrillation
NCT02583971 ·Status: UNKNOWN
-
Study of a New Anticoagulant Drug in Patients With Atrial Fibrillation
NCT00431782 ·Status: COMPLETED ·Phase: PHASE2
-
Bleeding Events and Oral Anticoagulant Treatment in Non-Valvular Atrial Fibrillation
NCT03002740 ·Status: WITHDRAWN
-
LAA Clipping Versus NOACs to Prevent Stroke in Non-paroxysmal Atrial Fibrillation.
NCT06021808 ·Status: RECRUITING ·Phase: NA
-
Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter
NCT02339493 ·Status: COMPLETED ·Phase: NA
-
Prevention Of Recurrence Of Atrial Fibrillation
NCT00041496 ·Status: COMPLETED ·Phase: PHASE2
-
A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor Blockers
NCT00321945 ·Status: COMPLETED
-
Stroke Prevention in Atrial Fibrillation Patients Between 2004 and 2020
NCT04686045 ·Status: UNKNOWN